Beyond renoprotective impact; ameliorative effects of metformin on malignancies
Diabetes therapies were associated with either a reduced or increased risk of cancer. There are continuous discussions about a possible protective action of metformin. In fact, metformin, a commonly consumed anti-diabetic medication has an ameliorative impact on some cancers by direct (preventing ce...
Main Authors: | Nozar Dorestan, Mohammad Bahadoram, Mohammadreza Khosravi, Sara Bahadoram, Mohammad Davoodi, Maedeh Barahman |
---|---|
Format: | Article |
Language: | English |
Published: |
Society of Diabetic Nephropathy Prevention
2018-05-01
|
Series: | Journal of Nephropharmacology |
Subjects: | |
Online Access: | http://jnephropharmacology.com/PDF/npj-7-50.pdf |
Similar Items
-
Metformin protects renal tubular cells; mechanisms and new concepts
by: Nozar Dorestan, et al.
Published: (2018-07-01) -
Impact of vitamin D deficiency on health with
regard to kidney disease; an updated mini-review
by: Nozar Dorestan, et al.
Published: (2018-05-01) -
Metformin, Asian ethnicity and risk of prostate cancer in type 2 diabetes: a systematic review and meta-analysis
by: Christopher B. Chen, et al.
Published: (2018-01-01) -
Metformin: A Bridge between Diabetes and Prostate Cancer
by: Veronica Zingales, et al.
Published: (2017-10-01) -
Understanding the Mechanisms of Diet and Outcomes in Colon, Prostate, and Breast Cancer; Malignant Gliomas; and Cancer Patients on Immunotherapy
by: Shivtaj Mann, et al.
Published: (2020-07-01)